Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lorus Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Carter Berezay who wrote (179)	6/5/1998 6:24:00 PM
From: trustmanic	Read Replies (1) \| Respond to of 279

Carter,the biotech jrs. are not doing well in this kind of market. Probably you can buy IMT for $0.80s next week. This will be another opportunity for a mid-term investor to buy low sell high. Just wait for a couple of months another cancer story will lift this stock up again. BNC is on the way up because of the new IR from Bank of Montreal? George

To: Carter Berezay who wrote (179)	6/14/1998 11:50:00 AM
From: nina	Read Replies (2) \| Respond to of 279

Hello Carter I guess there is nothing to say really except for deep disappoinment with the market's reaction to the last two announcements.I do agree with George that right now the biotech sector in Canada has been relegated to the bottom of the heap in this new strategy of sector rotation the the brokerages seem to be implementing. Really the only way I see this stock moving is if Imutec is prepared to do some major promotional work with various brokerage houses.I can only hope that they give this serious consideration before any further announcements are released. I bought this stock at a much higher level and am reluctant to average down at this stage. Cash is at a premium right now given market conditions and I don't want to tie it up for another six months or whatever period of time its going to be before some solid news is released.So IMT has gone back to my watchlist. If the IR officer from IMT is still perusing mail here it would be nice to hear from him and get a discussion going in terms of exactly what the implications were of last releases.